Answers are grounded in this paper and cite their sources.
We developed an injectable zwitterionic hydrogel from 2-methacryloyloxyethyl phosphorylcholine-based copolymers bearing lactobionamide or benzoxaborole units through reversible boroxole–carbohydrate crosslinking. The hydrogel exhibited frequency-dependent viscoelasticity and could be readily extruded through a syringe needle. Encapsulated alkaline phosphatase in the hydrogel retained approximately 95% of its activity after syringe extrusion and subsequent recovery, demonstrating the potential of the dynamic hydrogel as a reversible matrix for protein encapsulation and processing.
No takes yet. Share an insight, caveat, or question.
Madjid et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: